NEJM· @NEJM · X·· 4 小时前AI 评分20
AI 导读
在 #LIVES2026 上发布： 一项开放标签、随机、非劣效性试验显示，在合并急性肾损伤的危重症成人患者中，间歇性血液透析不劣于连续性肾脏替代治疗未获证实。ICRAKI试验完整结果：https://nej.md/472QMel 社论：连续性或间歇性肾脏替代治疗——问题是什么？https://nej.md/4egLaB1
正文
Presented at #LIVES2026:
An open-label, randomized, noninferiority trial showed that intermittent hemodialysis was not noninferior to continuous renal-replacement therapy in critically ill adults with acute kidney injury. Full ICRAKI trial results: https://nej.md/472QMel
Editorial: Continuous or Intermittent Renal-Replacement Therapy — What is the Question? https://nej.md/4egLaB1
来源：NEJM · x.com